2/n
Abbott test showed 100% specificity and just over 93% sensitivity for sera >14 day after symptom onset. Manufacturer claimed 100% sensitivity for sera >14 day post-onset.
3/n
In the #PHE validation, the Roche assay also showed 100% specificity and 87% sensitivity for sera obtained >14 day post symptom start. Meaning the assay would miss a previous infection in 1 out of 10 cases. Manufacturer claimed a sensitivity of 100% in their validation...
4/4
Take home message. Positive test means you have had a past #SARSCoV2 infection. Negative test doesn’t tell you anything - most likely not infected in the past, but you wont know for sure. And as the number of cases increases the chances if it being a true negative falls...
5/4
Correction - re-reading the test procedure it looks like all #Covid-19 samples were obtained in hospital setting. Will seek clarification...
But data still holds true.
6/4
‘...none of the patients with previously positive PCR who tested negative by this assay had been hospitalised for COVID-19 disease and most likely had a mild disease outcome.’ So, yes they included non-hospital admissions and importantly mild cases sometimes tested negative
7/4
This statement was included in the reports for both assays. Therefore, antibody testing to confirm community (mild) disease might lack sensitivity. This fits with the healthcare worker study @bealelab flagged to me yesterday. I will dig further...
You can follow @JonathanKBall.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: